Rcf Protecting Innovation patent opposition analysis

The comprehensive analysis of Rcf Protecting Innovation opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Rcf Protecting Innovation

Patent NumberTitleApplicantOpposition DateOpposition Company
Dosing Regimen For Anti-Bcma AgentsAMGEN RESEARCH (MUNICH) GMBHJul 11, 2024STRAWMAN
Dosing Regimen For Anti-Bcma AgentsAMGEN RESEARCH (MUNICH) GMBHMar 15, 2024STRAWMAN

Top companies who are the clients of Rcf Protecting Innovation

CompanyTotal
STRAWMAN2